Curis (CRIS) Gross Profit (2012 - 2025)
Curis' (CRIS) quarterly Gross Profit came in at $1.1 million in Q4 2025, down 65.81% YoY from $3.3 million in Q4 2024, and down 64.0% on a QoQ basis from $3.2 million in Q3 2025.
Curis (CRIS) Gross Profit (2012 - 2025) Analysis & Trends
Curis (CRIS) has 14 years of Gross Profit data on file, last reported at $1.1 million in Q4 2025.
- Quarterly Gross Profit fell 65.81% year-over-year to $1.1 million in Q4 2025, while the trailing twelve-month figure through Mar 2026 was $7.0 million (down 36.86% YoY) and the FY2025 annual result came in at $9.4 million, down 13.06% from the prior year.
- Gross Profit declined to $1.1 million in Q4 2025, from $3.2 million in the prior quarter.
- In the past five years, Gross Profit ranged from a high of $3.3 million in Q4 2024 to a low of $1.1 million in Q4 2025.
- A 5-year average of $2.5 million and a median of $2.6 million in 2023 frame the typical range for Gross Profit.
- Annual changes were most pronounced in 2024 — Gross Profit advanced 25.97% — and 2025, when it plunged 65.81%.
- Tracing CRIS's Gross Profit over 5 years: stood at $3.0 million in 2021, then dropped by 6.88% to $2.8 million in 2022, then dropped by 4.72% to $2.6 million in 2023, then gained by 25.97% to $3.3 million in 2024, then sank by 65.81% to $1.1 million in 2025.
- The last three Gross Profit figures came in at $1.1 million (Q4 2025), $3.2 million (Q3 2025), and $2.7 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Curis | 3.27 Mn | -2.35 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.14 Mn |
| Dec 31, 2025 | 1.14 Mn |
| Sep 30, 2025 | 3.16 Mn |
| Sep 30, 2025 | 3.16 Mn |
| Jun 30, 2025 | 2.73 Mn |
| Jun 30, 2025 | 2.73 Mn |
| Mar 31, 2025 | 2.37 Mn |
| Mar 31, 2025 | 2.37 Mn |
| Dec 31, 2024 | 3.33 Mn |
| Dec 31, 2024 | 3.33 Mn |
| Sep 30, 2024 | 2.91 Mn |
| Sep 30, 2024 | 2.91 Mn |
| Jun 30, 2024 | 2.53 Mn |
| Jun 30, 2024 | 2.53 Mn |
| Mar 31, 2024 | 2.04 Mn |
| Mar 31, 2024 | 2.04 Mn |
| Dec 31, 2023 | 2.64 Mn |
| Dec 31, 2023 | 2.64 Mn |
| Sep 30, 2023 | 2.77 Mn |
| Sep 30, 2023 | 2.77 Mn |